CVS Health (NYSE: CVS) and Walgreens Boots Alliance (NASDAQ: WBA) are two top names in healthcare. CVS is larger and more diverse than its rival, which focuses on pharmacy retail. But soon, the two could be on a collision course again as they both expand into primary care.

However, over the past year, their share prices have been diverging, with CVS stock rallying 21% while shares of Walgreens have plummeted by 27%. Will this trend continue, and are investors better off going with CVS, or can Walgreens rally from its lower price point?

CVS makes sense as an investment for risk-averse investors looking for diversification and overall stability. In the past 12 months, CVS' revenue totaled just under $308 billion. Walgreens generates less than half of that, reporting roughly $135 billion over its last four quarters.

Continue reading

Source Fool.com